Skip to main content
logo
Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
3.100
+0.240 (8.39%)
Aug 4, 2026, 3:19 PM EDT - Market open

Elicio Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----28.31
Revenue Growth
-----883.06%
Gross Profit
-----27.88
Operating Income
-37.58-37.71-44.99-35.75-23.73-39.31
Net Income
-40.19-39.57-51.9-35.2-28.21-54.57
Earnings Per Share
-2.40-2.58-4.25-6.96-89.27-19.30
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
14.9518.5617.6212.896.1688.76
Total Debt
14.3414.5126.046.927.484.37
Net Cash (Debt)
0.614.05-8.425.98-1.3384.39
Net Cash Growth
-95.16%-----
Net Cash Per Share
0.040.26-0.691.18-0.9057.16

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-38.48-36.95-37.07-32.69-22.18-52.64
Capital Expenditures
--0.02-0.09-0.07-0.65-0.38
Free Cash Flow
-38.48-36.97-37.16-32.76-22.83-53.03
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-----98.47%
Operating Margin
------138.84%
Pretax Margin
------138.26%
Profit Margin
------192.76%
FCF Margin
------187.29%

Valuation
Selected indicators aren't available for this stock.